Microscopic Polyangiitis Associated With Thymoma, Exacerbating After Thymectomy

American Journal of Kidney Diseases

Volumn 48, Issue 5, 2006, Pages 827-831

  Parambil, Joseph G ^a   Keogh, Karina A ^a   Fervenza, Fernando C ^a   Ryu, Jay H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Microscopic polyangiitis; rapidly progressive glomerulonephritis; thymoma

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; ROFECOXIB;

ADULT; ANAMNESIS; ANCA ASSOCIATED VASCULITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE EXACERBATION; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; LABORATORY TEST; MALE; MEDIASTINUM MASS; PHYSICAL EXAMINATION; POLYARTHRITIS; STERNOTOMY; THORAX RADIOGRAPHY; THYMECTOMY; THYMOMA;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOIMMUNE DISEASES; DISEASE PROGRESSION; GLOMERULONEPHRITIS; HUMANS; KIDNEY; MALE; MIDDLE AGED; NECROSIS; POSTOPERATIVE PERIOD; THYMECTOMY; THYMOMA; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS;

EID: 33750038270     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.07.020     Document Type: Article

References (24)

1. Specks U., and Homburger H.A. Anti-neutrophil cytoplasmic antibodies. Mayo Clin Proc 69 (1994) 1197-1198
2. Seo P., and Stone J.H. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 117 (2004) 39-50
3. Lockwood C.M. Specificity and pathogenicity of antineutrophil cytoplasmic antibodies. Exp Nephrol 1 (1993) 13-18
4. Sanders J.S., Stegeman C.A., and Kallenberg C.G. The Th1 and Th2 paradigm in ANCA-associated vasculitis. Kidney Blood Press Res 26 (2003) 215-220
5. Lamprecht P. Off balance: T-Cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 141 (2005) 201-210
6. Haynes B.F., and Hale L.P. The human thymus. A chimeric organ comprised of central and peripheral lymphoid components. Immunol Res 18 (1998) 175-192
7. Muller-Hermelink H.K., and Marx A. Thymoma. Curr Opin Oncol 12 (2000) 426-433
8. Levy Y., Afek A., Sherer Y., et al. Malignant thymoma associated with autoimmune diseases: A retrospective study and review of the literature. Semin Arthritis Rheum 28 (1998) 73-79
9. Irvine W.J. Immunobiology of the thymus and its relation to autoimmune disease. Mod Trends Immunol 2 (1967) 250-291
10. Souadjian J.V., Enriquez P., Silverstein M.N., and Pepin J.M. The spectrum of diseases associated with thymoma. Coincidence or syndrome?. Arch Intern Med 134 (1974) 374-379
11. Jaretzki A., Steinglass K.M., and Sonett J.R. Thymectomy in the management of myasthenia gravis. Semin Neurol 24 (2004) 49-62
12. Masaoka A., Hashimoto T., Shibata K., Yamakawa Y., Nakamae K., and Iizuka M. Thymomas associated with pure red cell aplasia. Cancer 64 (1989) 1872-1878
13. Bozzolo E., Bellone M., Quaroni N., Voci C., and Sabbadini M.G. Thymoma associated with systemic lupus erythematosus and immunologic abnormalities. Lupus 9 (2000) 151-154
14. Boonen A., Rennenberg R., and van der Linden S. Thymoma-associated systemic lupus erythematosus, exacerbating after thymectomy. A case report and review of the literature. Rheumatology 39 (2000) 1044-1046
15. Savage C.O., Winearls C.G., Evans D.J., Rees A.J., and Lockwood C.M. Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med 56 (1985) 467-483
16. George T.M., Cash J.M., Farver C., et al. Mediastinal mass and hilar adenopathy: Rare thoracic manifestations of Wegener's granulomatosis. Arthritis Rheum 40 (1997) 1992-1997
17. Karras A., de Montpreville V., Fakhouri F., Grunfeld J.P., and Lesavre P. Renal and thymic pathology in thymoma-associated nephropathy: Report of 21 cases and review of the literature. Nephrol Dial Transplant 20 (2005) 1075-1082
18. Valli G., Fogazzi G.B., Cappellari A., and Rivolta E. Glomerulonephritis associated with myasthenia gravis. Am J Kidney Dis 31 (1998) 350-355
19. Vittecoq O., Jouen-Beades F., Tron F., and Le Loet X. Antibodies and vascular involvement in inflammatory joint disease: Clinical relevance. Joint Bone Spine 68 (2001) 466-476
20. Jagiello P., Aries P., Arning L., et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 52 (2005) 4039-4043
21. Sneller M.C. Granuloma formation, implications for the pathogenesis of vasculitis. Cleveland Clin J Med 69 (2002) 40-42
22. Kawauchi H., Taniguchi K., Kubo C., Shimamoto Y., and Nomoto K. The mechanism of reduction of cell-mediated cytotoxicity in neonatally thymectomized mice. Immunology 50 (1998) 199-205
23. Steinberg A.D., Law L.D., and Talal N. The role of NZB/NZW F1 thymus in experimental tolerance and autoimmunity. Arthritis Rheum 13 (1970) 369-377
24. Steinberg A.D., Roths J.B., Murphy E.D., Steinberg R.T., and Raveche E.S. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/ lpr mice. J Immunol 125 (1980) 871-873